Press Releases

NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Rise, the flexible work platform for leading women, announced a partnership today with health insurance administrator Decent, to provide affordable health insurance options for women without access to employer-sponsored plans. The program launched in Austin, TX on November 1

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Viracta Therapeutics, Inc. (the "Company"), a precision oncology company targeting virus-associated malignancies, announced today that the U.S. Food and Drug A

YOQNEAM, Israel, Nov. 12, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, will pres

LOS ANGELES, Nov. 12, 2019 /PRNewswire/ -- In a major acquisition for financial technology startup Scratchpay (and Silicon Beach), Jin Han, former Chief Lending Co

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late‐stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Daniel P. Gold, Ph.D., president and chief executive officer, will present at the Stifel 2019 Healthcare Conference on Tuesday, No

HOUSTON, Nov. 12, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, announced that the FDA has approved a request for Investigational New Drug ("IND") status for its drug candidate WP1066 to be used in a Phas

HOUSTON, Nov. 12, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has begun the first follow-up visits for pati

MOUNT ROYAL, N.J., Nov. 12, 2019 /PRNewswire/ -- The American Migraine Foundation (AMF) is proud to announce that Jim Cramer, host of CNBC's Mad Money, has joined the organization as its spokesperson. Mr. Cramer will be an instrumental figure in the Foundation's mission to drive awareness, advance research and provide education

MARLBOROUGH, Mass., Nov. 12, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INSTASYL™) therapeutic platform, today reported its financial results for the third quarter ended September 30, 2019

GERMANTOWN, Md., Nov. 12, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health o